Table 6.
Summary of findings: effective bedaquiline-including regimens
| In animal model studies | In human studies | ||
|---|---|---|---|
| Regimen | Mycobacterium species | Regimen | Species |
| RIF or RFP and/or Q203 or CLF | M. ulcerans | BDQ + LVX | M. fortuitum |
| CLR and/or AMK | M. avium | BDQ + OMC or CLF | M. abscessus |
| BDQ combined with either IPM or CLF | M. abscessus | BDQ + MFX | M. marinum |
| BDQ + TDZ and CLF | M. avium | ||
RIF, rifampicin; AMK, amikacin; BDQ, bedaquiline; CLF, clofazimine; CLR, clarithromycin; IPM, imipenem; RFP, rifapentine; Q203, telacebec; MFX, moxifloxacin; OMC, omadacycline; TDZ, tedizolid; LVX, levofloxacin.